How Do We Tackle Residual Inflammation in Psoriasis Patients on Biologic Therapy?
Journal of Inflammation Research · 2026-11 · Volume 19 · 1-8
DOI: 10.2147/jir.s614507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-11. Verfasst von Luisa Boeti und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Boeti, L., Mastrogiovanni, A., Luca, E. D., Simone, C. D., Peris, K., & Caldarola, G. (2026). How Do We Tackle Residual Inflammation in Psoriasis Patients on Biologic Therapy?. Journal of Inflammation Research, Volume 19, 1-8. https://doi.org/10.2147/jir.s614507
Vancouver
Boeti L, Mastrogiovanni A, Luca ED, Simone CD, Peris K, Caldarola G. How Do We Tackle Residual Inflammation in Psoriasis Patients on Biologic Therapy?. Journal of Inflammation Research. 2026;Volume 19:1-8. doi:10.2147/jir.s614507
BibTeX
@article{Boeti2026,
author = {Boeti, Luisa and Mastrogiovanni, Andrea and Luca, Eleonora De and Simone, Clara De and Peris, Ketty and Caldarola, Giacomo},
title = {How Do We Tackle Residual Inflammation in Psoriasis Patients on Biologic Therapy?},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--8},
doi = {10.2147/jir.s614507}
}
EUVIMED